Breast Cancer News

As many as half of cancer-signaling proteins once thought to be resistant to drug treatment due to lack of targetability may, in fact, be treatable, a study conducted at Perelman School of Medicine at the University of Pennsylvania showed.

In a phase 1 trial of mistletoe extract for patients with cancer, researchers at Johns Hopkins Kimmel Cancer Center found the therapy to not only be safe but also potentially beneficial to quality of life.

University of Chicago Medicine Comprehensive Cancer Center has joined the National Comprehensive Cancer Network as its 33rd member institution.

A therapy commonly used for gender affirmation in transgender men potentially could have a role in the development of therapies for ER-positive breast cancer, according to a study published in Cell Genomics.

HHS on Monday released the National Cancer Plan, which includes eight goals and strategies to prevent cancer, reduce related mortality and improve the lives of people living with the disease.

Kerin Adelson, MD, has been named chief quality and value officer at The University of Texas MD Anderson Cancer Center.

Vanessa B. Sheppard, PhD, received American Cancer Society’s 2022 Researcher of the Year Award.

The Healio Editors compiled a list of recent news from the Society of Gynecologic Oncology Annual Meeting held from March 25-28, 2023.

Racial and ethnic subtype-specific differences in pathologic complete response rates after neoadjuvant chemotherapy for breast cancer may partially account for worse survival rates for Black women, according to study data.

FDA granted full approval to pembrolizumab for treatment of certain adults and children with unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors as determined through an FDA-approved test.